R. Perng

J. Whang‐Peng, T. Chou, Yuh-Min Chen, 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Number of liver metastatic nodules affects treatment options for pulmonary adenocarcinoma patients with liver metastases.

Yuh-Min Chen, R. Perng, Yu-chin Lee, 2014, Lung cancer.

Schedule‐dependent in vitro combination effects of methotrexate and 5‐fluorouracil in human tumor cell lines

B. Kramer, A. Gazdar, R. Perng, 1991, International journal of cancer.

High efficacy of erlotinib in Taiwanese NSCLC patients in an expanded access program study previously treated with chemotherapy.

Chih-Hsin Yang, H. Kuo, Yuh-Min Chen, 2008, Lung cancer.

Lupus erythematosus (LE) cells in ascites: initial diagnosis of systemic lupus erythematosus by cytological examination: a case report

R. Perng, Yu-chin Lee, K. Chou, 2007, Clinical Rheumatology.

Gemcitabine versus the combination of cisplatin and etoposide in patients with inoperable non-small-cell lung cancer in a phase II randomized study.

J. Whang‐Peng, R. Perng, C. Tsai, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Modulation of cisplatin resistance in acquired-resistant nonsmall cell lung cancer cells.

J. Whang‐Peng, R. Perng, S. Lai, 1995, Oncology research.

Prognosis and recurrent patterns in bronchioloalveolar carcinoma.

R. Perng, M. Huang, Y. Chen, 2000, Chest.

Survival Status of Veterans with Lung Cancer Is Poorer Than That Among Civilians Due to Age and Sex Differences: A Study of Chinese Veterans in Taiwan

Yuh-Min Chen, R. Perng, Chun-Ming Tsai, 2008, Journal of the Chinese Medical Association : JCMA.

Correlation of intrinsic chemoresistance of non-small-cell lung cancer cell lines with HER-2/neu gene expression but not with ras gene mutations.

A. Gazdar, T. Mitsudomi, Kuo‐Ting Chang, 1993, Journal of the National Cancer Institute.

Phase II randomized study of weekly docetaxel alone or plus UFUR treatment in non-small cell lung cancer patients who failed previous chemotherapy.

J. Whang‐Peng, Yuh-Min Chen, R. Perng, 2008, Lung cancer.

A randomized phase II study of docetaxel or vinorelbine in combination with cisplatin against inoperable, chemo-naïve non-small-cell lung cancer in Taiwan.

J. Whang‐Peng, Yuh-Min Chen, R. Perng, 2007, Lung cancer.

A Phase II Randomized Study of Paclitaxel Plus Carboplatin or Cisplatin against Chemo-Naive Inoperable Non-small Cell Lung Cancer in the Elderly

J. Whang‐Peng, Yuh-Min Chen, R. Perng, 2006, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

A randomized phase II study of vinorelbine plus gemcitabine with/without cisplatin against inoperable non-small-cell lung cancer previously untreated.

J. Whang‐Peng, Yuh-Min Chen, R. Perng, 2005, Lung Cancer.

Paclitaxel plus carboplatin, compared with paclitaxel plus gemcitabine, shows similar efficacy while more cost-effective: a randomized phase II study of combination chemotherapy against inoperable non-small-cell lung cancer previously untreated.

J. Whang‐Peng, Yuh-Min Chen, R. Perng, 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

A phase II study of single-agent docetaxel chemotherapy for non-small cell lung cancer.

R. Perng, C. Tsai, J. Shih, 2000, Japanese journal of clinical oncology.

A randomized trial of different docetaxel schedules in non-small cell lung cancer patients who failed previous platinum-based chemotherapy.

J. Whang‐Peng, Yuh-Min Chen, R. Perng, 2006, Chest.

Pemetrexed Followed by Docetaxel or a Reverse Sequence in Non-Small-Cell Lung Cancer

Yuh-Min Chen, R. Perng, Yu-chin Lee, 2009 .

Effects of body position and age on membrane diffusing capacity and pulmonary capillary blood volume.

R. Perng, S. C. Chang, G. Shiao, 1992, Chest.

Salvage Therapy for Chinese Non-small Cell Lung Cancer Patients Who Failed Previous Chemotherapy

J. Whang‐Peng, Yuh-Min Chen, R. Perng, 2006, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

An analysis of cytokine status in the serum and effusions of patients with tuberculous and lung cancer.

J. Whang‐Peng, Yuh-Min Chen, R. Perng, 2001, Lung cancer.

Interstitial pneumonia during gefitinib treatment of non-small-cell lung cancer.

C. Chiu, R. Perng, Chun-Ming Tsai, 2005, Journal of the Chinese Medical Association : JCMA.

Clinical Experience with Single‐Agent Gemcitabine Chemotherapy in Patients with Non‐Small‐Cell Lung Cancer in Whom Previous Chemotherapy Has Failed

Yuh-Min Chen, R. Perng, Chun-Ming Tsai, 2005, Journal of the Chinese Medical Association : JCMA.

Adenocarcinoma of the lung presenting as a mycetoma with an air crescent sign.

Yuh-Min Chen, R. Perng, Hsi Chu, 2007, Chest.

A prospective study of the use of circulating markers as predictors for epidermal growth factor receptor-tyrosine kinase inhibitor treatment in pulmonary adenocarcinoma.

J. Whang‐Peng, Yuh-Min Chen, R. Perng, 2016, Cancer biomarkers : section A of Disease markers.

Phase II trial of intrapleural paclitaxel injection for non-small-cell lung cancer patients with malignant pleural effusions.

J. Whang‐Peng, Yuh-Min Chen, R. Perng, 1998, Respiratory medicine.

Tuberculous subcutaneous abscess: an analysis of seven cases.

R. Perng, J. Shih, L. Wang, 1996, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Restoration of cytotoxic T lymphocyte function in malignant pleural effusion: interleukin-15 vs. interleukin-2.

R. Perng, W. Yang, C. Tsai, 2000, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Cross regulation by IL-10 and IL-2/IL-12 of the helper T cells and the cytolytic activity of lymphocytes from malignant effusions of lung cancer patients.

W. Tsai, R. Perng, W. Yang, 1997, Chest.

Elevation of interleukin-10 levels in malignant pleural effusion.

J. Whang‐Peng, R. Perng, W. Yang, 1996, Chest.

Usefulness of pig-tail catheter for palliative drainage of malignant pleural effusions in cancer patients

Yuh-Min Chen, R. Perng, Yu-chin Lee, 2000, Supportive Care in Cancer.

Prognostic role of pericardial fluid cytology in cardiac tamponade associated with non-small cell lung cancer.

R. Perng, Kuang-Yao Yang, S. Yen, 2000, Chest.

Genetic variant in TP63 on locus 3q28 is associated with risk of lung adenocarcinoma among never-smoking females in Asia

Wen Tan, Chien-Chung Lin, Chang Ho Kim, 2012, Human Genetics.

Enhanced chemoresistance by elevation of p185neu levels in HER-2/neu-transfected human lung cancer cells.

N. Ibrahim, M. Hung, Kuo‐Ting Chang, 1995, Journal of the National Cancer Institute.

Leukotriene C4 induces TGF-beta1 production in airway epithelium via p38 kinase pathway.

Kuo‐Ting Chang, R. Perng, Yu-Chung Wu, 2006, American journal of respiratory cell and molecular biology.

Lung Cancer Associated with Rheumatoid Arthritis Does Not Shorten Life Expectancy

Yuh-Min Chen, R. Perng, S. Yen, 2005, Journal of the Chinese Medical Association : JCMA.

IV delivery of induced pluripotent stem cells attenuates endotoxin-induced acute lung injury in mice.

Hsin-Yang Li, S. Chiou, R. Perng, 2011, Chest.

Additive benefits of tiotropium in COPD patients treated with long‐acting β2 agonists and corticosteroids

R. Perng, D. Perng, K. Su, 2006, Respirology.

Inhaled Fluticasone and Salmeterol Suppress Eosinophilic Airway Inflammation in Chronic Obstructive Pulmonary Disease: Relations with Lung Function and Bronchodilator Reversibility

R. Perng, D. Perng, K. Su, 2006, Lung.

Characteristics of airway inflammation and bronchodilator reversibility in COPD: a potential guide to treatment.

R. Perng, Hua-Ming Chen, D. Perng, 2004, Chest.

Double-blind randomized parallel group study comparing the efficacy and safety of tiotropium and ipratropium in the treatment of COPD patients in Taiwan.

R. Perng, Pan‐Chyr Yang, M. Huang, 2006, Journal of the Formosan Medical Association = Taiwan yi zhi.

Temporal relationship between cancers of the lung and upper aerodigestive tract.

R. Perng, Y. Chen, W. Hsieh, 1997, Japanese journal of clinical oncology.

Efficacy and Safety of Nemonoxacin versus Levofloxacin for Community-Acquired Pneumonia

R. Perng, C. King, Yu-Ting Chang, 2010, Antimicrobial Agents and Chemotherapy.

Efﬁcacy and Safety of Nemonoxacin versus Levoﬂoxacin for Community-Acquired Pneumonia (cid:1)

R. Perng, C. King, Yu-Ting Chang, 2010 .

Familial sarcoidosis in Taiwan.

R. Perng, K. Chou, Yu-Mei Chung, 2007, Journal of the Formosan Medical Association = Taiwan yi zhi.

Phase II study with gemcitabine, ifosfamide and cisplatin in advanced non-small cell lung cancer.

J. Whang‐Peng, R. Perng, C. Tsai, 2000, Lung cancer.

A phase II trial of tamoxifen, ifosfamide, epirubicin, and cisplatin combination chemotherapy for inoperable non-small-cell lung cancer.

J. Whang‐Peng, R. Perng, C. Tsai, 2000, American journal of clinical oncology.

Interrelationships between Cellular Nucleotide Excision Repair, Cisplatin Cytotoxicity, HER‐2/neu Gene Expression, and Epidermal Growth Factor Receptor Level in Non‐small Cell Lung Cancer Cells

Kuo‐Ting Chang, R. Perng, Chun-Ming Tsai, 2000, Japanese journal of cancer research : Gann.

Phase II Study of Gemcitabine and Vinorelbine Combination Chemotherapy in Patients With Non–Small-Cell Lung Cancer Not Responding to Previous Chemotherapy

J. Whang‐Peng, Yuh-Min Chen, R. Perng, 2003, American journal of clinical oncology.

Phase II study of docetaxel and ifosfamide combination chemotherapy in non-small-cell lung cancer patients failing previous chemotherapy with or without paclitaxel.

Yuh-Min Chen, R. Perng, Chun-Ming Tsai, 2003, Lung cancer.

Vandetanib versus placebo in patients with advanced non-small cell lung cancer (NSCLC) after prior therapy with an EGFR tyrosine kinase inhibitor (TKI): A randomized, double-blind phase III trial (ZEPHYR).

Keunchil Park, R. Perng, J. S. Lee, 2010 .

Non-Small Cell Lung Cancer Cell Lines1

A. Gazdar, T. Mitsudomi, Kuo‐Ting Chang, 1996 .

Effect of body position on gas exchange in patients with unilateral central airway lesions. Down with the good lung?

R. Perng, G. Shiao, H. Chang, 1993, Chest.

Randomized, double-blind, placebo-controlled study of transdermal nicotine patch for smoking cessation.

R. Perng, Y. Chen, C. Lu, 1998, Journal of the Formosan Medical Association = Taiwan yi zhi.

Interleukin-2 stimulation activates mesothelial cellular functioning against autologous tumor cells.

Yuh-Min Chen, R. Perng, Chun-Ming Tsai, 2004, Journal of the Chinese Medical Association : JCMA.

Double signal stimulation was required for full recovery of the autologous tumor-killing effect of effusion-associated lymphocytes.

J. Whang‐Peng, Yuh-Min Chen, R. Perng, 2002, Chest.

Life-threatening hypersensitivity pneumonitis induced by docetaxel (taxotere)

R. Perng, G-S Wang, K. Yang, 2001, British Journal of Cancer.

Serum cytokine level fluctuations in chemotherapy-induced myelosuppression.

J. Whang‐Peng, Yuh-Min Chen, R. Perng, 1996, Japanese journal of clinical oncology.

The effect of cyclosporine on expression of class II major histocompatibility complex antigens on bronchoalveolar cells and peripheral blood mononuclear cells.

R. Perng, G. Shiao, C. Y. Lin, 1990, Immunology Letters.

Combination cytotoxic effects of cis-diamminedichloroplatinum(II) and 5-fluorouracil with and without leucovorin against human non-small cell lung cancer cell lines.

B. Kramer, A. Gazdar, R. Perng, 1993, Cancer research.

Interactions between household air pollution and GWAS-identified lung cancer susceptibility markers in the Female Lung Cancer Consortium in Asia (FLCCA)

Hongbing Shen, Chien-Jen Chen, N. Rothman, 2015, Human Genetics.

Genetic variant in TP63 on locus 3q28 is associated with risk of lung adenocarcinoma among never-smoking females in Asia

B. Qian, Chien-Jen Chen, N. Rothman, 2012, Human Genetics.

Lymph node tuberculosis: 7-year experience in Veterans General Hospital, Taipei, Taiwan.

R. Perng, W. Su, Y. Chen, 1992, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Phase II study of tamoxifen, ifosfamide, epirubicin and cisplatin combination chemotherapy in patients with non-small cell lung cancer failing previous chemotherapy.

J. Whang‐Peng, R. Perng, C. Tsai, 2000, Lung cancer.

Involvement of phosphatidylinositol 3-kinase gamma in neutrophil apoptosis.

R. Perng, E. Abraham, T. Pitts, 2003, Cellular signalling.

Gefitinib is active in patients with brain metastases from non-small cell lung cancer and response is related to skin toxicity.

C. Chiu, Yuh-Min Chen, R. Perng, 2005, Lung cancer.

Decoy receptor 3 levels in peripheral blood predict outcomes of acute respiratory distress syndrome.

T. Chou, R. Perng, Pan‐Chyr Yang, 2009, American journal of respiratory and critical care medicine.

Utility of PCR assays for rapid diagnosis of BCG infection in children.

R. Perng, W. Su, C. Huang, 2001, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Superior vena cava syndrome caused by encapsulated pleural effusion.

R. Perng, C. Lai, T. Tsai, 1997, The European respiratory journal.

Leukemoid reaction resulting from multiple cytokine production in metastatic mucoepidermoid carcinoma with central necrosis.

J. Whang‐Peng, R. Perng, J. M. Liu, 1995, Japanese journal of clinical oncology.

Peritoneal carcinomatosis in lung cancer

R. Perng, Chun-Ming Tsai, H. Su, 2008, Respirology (Carlton South. Print).

Impact of nutritional status on the survival of lung cancer patients.

R. Perng, S. Lai, 1998, Zhonghua yi xue za zhi = Chinese medical journal; Free China ed.

Enhancement of fluorinated pyrimidine‐induced cytotoxicity by leucovorin in human lung cancer cell lines

B. Kramer, A. Gazdar, R. Perng, 1990, International journal of cancer.

Tuberculosis infection and lung adenocarcinoma: Mendelian randomization and pathway analysis of genome-wide association study data from never-smoking Asian women.

X. Hua, Jianxin Shi, Y. Miyagi, 2019, Genomics.

Association between GWAS-identified lung adenocarcinoma susceptibility loci and EGFR mutations in never-smoking Asian women, and comparison with findings from Western populations

Ping Wang, Junjie Wu, Jian Su, 2016, Human molecular genetics.

Analysis of Heritability and Shared Heritability Based on Genome-Wide Association Studies for Thirteen Cancer Types.

Jian Su, Wen Tan, Paolo Vineis, 2015, Journal of the National Cancer Institute.

Analysis of Heritability and Shared Heritability Based on Genome-Wide Association Studies for 13 Cancer Types

Alison P. Klein, William Wheeler, Li Jin, 2015 .

The 5p15.33 Locus Is Associated with Risk of Lung Adenocarcinoma in Never-Smoking Females in Asia

Chung K. Chang, Hongbing Shen, N. Rothman, 2010, PLoS genetics.

Serum tumor markers as predictors for survival in advanced non-small cell lung cancer patients treated with gefitinib.

C. Chiu, Yuh-Min Chen, R. Perng, 2007, Lung cancer.

Erlotinib has better efficacy than gefitinib in adenocarcinoma patients without EGFR-activating mutations, but similar efficacy in patients with EGFR-activating mutations.

J. Whang‐Peng, C. Chiu, Yuh-Min Chen, 2012, Experimental and therapeutic medicine.

Different Efficacies of Erlotinib and Gefitinib in Taiwanese Patients with Advanced Non-small Cell Lung Cancer: A Retrospective Multicenter Study

Yuh-Min Chen, R. Perng, Chun-Ming Tsai, 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Significance of biochemical markers in early detection of canine lung allograft rejection.

R. Perng, H. Hsu, G. Shiao, 1991, Transplantation.

Primary lung cancer complicated with pneumothorax.

R. Perng, R. Lai, S. C. Chang, 1992, Japanese Journal of Clinical Oncology.

Pneumothorax following cytotoxic chemotherapy in malignant lymphoma.

R. Perng, S. C. Chang, Shi‐Chuan Chang, 1990, Chest.

Gefitinib as front-line treatment in Chinese patients with advanced non-small-cell lung cancer.

C. Chiu, Yuh-Min Chen, R. Perng, 2006, Lung cancer.

Plasma soluble vascular endothelial growth factor receptor-1 levels predict outcomes of pneumonia-related septic shock patients: a prospective observational study

R. Perng, Kuang-Yao Yang, Kuan-Ting Liu, 2011, Critical care.

Vandetanib Versus placebo in patients with advanced non-small-cell lung cancer after prior therapy with an epidermal growth factor receptor tyrosine kinase inhibitor: a randomized, double-blind phase III trial (ZEPHYR).

Keunchil Park, Yuh-Min Chen, R. Perng, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A randomised phase II study of weekly paclitaxel or vinorelbine in combination with cisplatin against inoperable non-small-cell lung cancer previously untreated

J. Whang‐Peng, R. Perng, J. Shih, 2004, British Journal of Cancer.

Phase II Study with Vinorelbine and Cisplatin in Ad vanced Non-Small Cell Lung Can cer After Fail ure of Pre vi ous

Yuh-Min Chen, R. Perng, Chun-Ming Tsai, 2003 .

Phase II Study of Docetaxel and Gemcitabine Combination Chemotherapy in Non–Small-Cell Lung Cancer Patients Failing Previous Chemotherapy

J. Whang‐Peng, Yuh-Min Chen, R. Perng, 2002, American journal of clinical oncology.

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Treatment Response in Advanced Lung Adenocarcinomas with G719X/L861Q/S768I Mutations

Cheng-Ta Yang, Chun-Ming Tsai, Chun-Liang Lai, 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Epidermal Growth Factor Receptor (EGFR)-Tyrosine Kinase Inhibitor Treatment and Salvage Chemotherapy in EGFR-Mutated Elderly Pulmonary Adenocarcinoma Patients.

J. Whang‐Peng, Yuh-Min Chen, R. Perng, 2015, The oncologist.

Plasma epidermal growth factor receptor mutation analysis and possible clinical applications in pulmonary adenocarcinoma patients treated with erlotinib.

J. Whang‐Peng, T. Chou, Yuh-Min Chen, 2012, Oncology letters.

A multicenter phase II trial of vinorelbine plus gemcitabine in previously untreated inoperable (Stage IIIB/IV) non-small cell lung cancer.

J. Whang‐Peng, R. Perng, C. Tsai, 2000, Chest.

Efficacy and Safety of Erlotinib in 1242 East/South-East Asian Patients with Advanced Non-small Cell Lung Cancer

Keunchil Park, T. Mok, Yi-long Wu, 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Gefitinib (IRESSA) in Patients of Asian Origin with Refractory Advanced Non-small Cell Lung Cancer: Subset Analysis from the ISEL Study

S. Thongprasert, C. Watkins, R. Perng, 2006, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

The epidermal growth factor receptor‐tyrosine kinase inhibitor era has changed the causes of death of patients with advanced non‐small‐cell lung cancer

J. Whang‐Peng, Yuh-Min Chen, R. Perng, 2013, Journal of the Chinese Medical Association : JCMA.

Erlotinib or Chemotherapy in Second-Line or Later Treatment of Tumor EGFR Wild-Type Pulmonary Adenocarcinoma Patients

J. Whang‐Peng, Yuh-Min Chen, R. Perng, 2015 .

Extralobar pulmonary sequestration presenting as an anterior mediastinal tumor in an adult.

R. Perng, W. Su, S. C. Chang, 1993, Chest.

Anomalous systemic arterial supply to normal basilar segments of the lower lobe of the left lung.

R. Perng, C. Tao, W. Li, 1992, Chest.

Anomalous systemic arterial supply to normal basilar segments of the left lower lobe of the lung: a case report.

R. Perng, M. Chern, C. Tao, 1994, Zhonghua yi xue za zhi = Chinese medical journal; Free China ed.

Sub-multiplicative interaction between polygenic risk score and household coal use in relation to lung adenocarcinoma among never-smoking women in Asia.

Jianxin Shi, Hongbing Shen, N. Rothman, 2020, Environment International.

Genetic variants associated with longer telomere length are associated with increased lung cancer risk among never‐smoking women in Asia: a report from the female lung cancer consortium in Asia

B. Qian, Hongbing Shen, Chien-Jen Chen, 2015, International journal of cancer.

Interleukin-7 and interleukin-12 have different effects in rescue of depressed cellular immunity: comparison of malignant and tuberculous pleural effusions.

J. Whang‐Peng, R. Perng, C. Tsai, 2001, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Tuberculous subcutaneous abscesses developing during chemotherapy for pulmonary tuberculosis.

R. Perng, J. Tsai, J. Shih, 1993, Scandinavian journal of infectious diseases.

[Bronchopulmonary sequestration and pseudosequestration].

R. Perng, M. Chern, R. Lai, 1991, Zhonghua yi xue za zhi = Chinese medical journal; Free China ed.

Necrotizing fasciitis: is it a fatal complication of tube thoracostomy?--Report of three cases.

R. Perng, W. Su, Y. Chen, 1992, Respiratory Medicine.

Revisit of primary malignant neoplasms of the trachea: clinical characteristics and survival analysis.

R. Perng, Y. Chen, K. Yang, 1997, Japanese journal of clinical oncology.

Disconnection of a venous Port-A-Cath followed by embolization after saline flush: rare case report.

R. Perng, C. Tsai, Y. Chen, 1999, Japanese journal of clinical oncology.

Abdominal tuberculosis in Taiwan: a report from Veterans' General Hospital, Taipei.

R. Perng, Y. Chen, P. Lee, 1995, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Increasing drug resistance of Mycobacterium tuberculosis isolates in a medical center in northern Taiwan.

R. Perng, W. Su, Jia-Yih Feng, 2008, Journal of the Formosan Medical Association = Taiwan yi zhi.

Hydrochlorothiazide-induced pulmonary edema: a case report and literature review.

R. Perng, J. Tsai, C. Tao, 1992, Zhonghua yi xue za zhi = Chinese medical journal; Free China ed.

Intrathecal gemcitabine chemotherapy for non-small cell lung cancer patients with meningeal carcinomatosis--a case report.

Yuh-Min Chen, R. Perng, Chun-Ming Tsai, 2003, Lung cancer.

Clinical role of bronchoscopy in adults with intrathoracic tuberculous lymphadenopathy.

R. Perng, P. Lee, S. C. Chang, 1988, Chest.

Lung cancer may develop subsequently or coincidently with pulmonary alveolar proteinosis.

Yuh-Min Chen, R. Perng, K. Su, 2007, Lung cancer.

Pleural Effusion and Serum Soluble Fas-Ligand Levels Are Elevated in Different Clinical Conditions

R. Perng, C. Tsai, Y. Chen, 2002, Lung.

Fixed-dose combination chemotherapy (Rifater/Rifinah) for active pulmonary tuberculosis in Taiwan: a two-year follow-up.

R. Perng, W. Su, 2002, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Predictive Factors of Gefitinib Antitumor Activity in East Asian Advanced Non-small Cell Lung Cancer Patients

J. Shih, C. Chiu, R. Perng, 2006, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Silicone fluid-induced pulmonary embolism.

R. Perng, Y. Chen, C. Lu, 1993, The American review of respiratory disease.

Symptomatic ocular metastases in lung cancer

Yuh-Min Chen, R. Perng, H. Su, 2008, Respirology.

Hormone replacement therapy and lung cancer risk in Chinese

Chien-Jen Chen, R. Perng, C. Hsiung, 2007, Cancer.

Revisit of 1997 TNM staging system--survival analysis of 1112 lung cancer patients in Taiwan.

Jen-Jyh Lee, C. Chiu, Yuh-Min Chen, 2007, Japanese journal of clinical oncology.

Drug resistance of Mycobacterium tuberculosis isolated from patients at a medical center in Taiwan.

R. Perng, W. Su, P. Lee, 1997, Zhonghua yi xue za zhi = Chinese medical journal; Free China ed.

Eight-Month Prospective Study of 14 Patients With Hospital-Acquired Severe Acute Respiratory Syndrome

R. Perng, W. Su, C. Chiang, 2004, Mayo Clinic Proceedings.

Increased expression of MHC class II antigens in rejecting canine lung allografts.

R. Perng, H. Hsu, G. Shiao, 1990, Transplantation.

Mutation in theTyrosine Kinase Domain of Epidermal Growth Factor Receptor Is a Predictive and Prognostic Factor for Gefitinib Treatment in Patients with Non ^ Small Cell Lung Cancer

T. Chou, C. Chiu, Ling-Hui Li, 2005 .

Enhancement of chemosensitivity by tyrphostin AG825 in high-p185(neu) expressing non-small cell lung cancer cells.

Kuo‐Ting Chang, R. Perng, A. Levitzki, 1996, Cancer research.

Multiple primary malignancies involving lung cancer-clinical characteristics and prognosis.

Yuh-Min Chen, R. Perng, Chun-Ming Tsai, 2002, Lung cancer.

Circulating free mitochondrial DNA concentration and its association with erlotinib treatment in patients with adenocarcinoma of the lung

J. Whang‐Peng, Yuh-Min Chen, R. Perng, 2014, Oncology letters.

The value of roentgenographic and fiberbronchoscopic findings in predicting outcome of adults with lower lung field tuberculosis.

R. Perng, P. Lee, S. C. Chang, 1991, Archives of internal medicine.

Lower lung field tuberculosis.

R. Perng, P. Lee, S. C. Chang, 1987, Chest.

A phase II study of oral vinorelbine in combination with cisplatin conducted in Taiwan in patients with unresectable localized or metastatic non-small cell lung carcinoma.

Yuh-Min Chen, R. Perng, Chun-Ming Tsai, 2007, Lung cancer.

Evaluation of the Relative Cytotoxic Effects of Anticancer Agents in Serum‐supplemented versus Serum‐free Media Using a Tetrazolium Colorimetric Assay

A. Gazdar, D. Venzon, Kuo‐Ting Chang, 1996, Japanese journal of cancer research : Gann.

Shortened survival of lung cancer patients initially presenting with pulmonary tuberculosis.

R. Perng, Y M Chen, J Y Chao, 1996, Japanese Journal of Clinical Oncology.

Nd-YAG Laser Treatment for Tracheobronchial Obstruction

R. Perng, Yu-chin Lee, Kuo-Hwa Chiang, 1996, Diagnostic and therapeutic endoscopy.

Preliminary report of a randomized trial of different docetaxel schedules in non-small cell lung cancer patients failing previous chemotherapy.

J. Whang‐Peng, R. Perng, J. Shih, 2004, Journal of Clinical Oncology.

Effect of Age on Pulmonary Metastases and Immunotherapy in Young and Middle‐aged Mice

J. Whang‐Peng, Yuh-Min Chen, R. Perng, 2007, Journal of the Chinese Medical Association : JCMA.

Effect of age on tumor metastases and immunotherapy than the middle-aged mice after IV of B 16 melanoma cells

J. Whang‐Peng, Yuh-Min Chen, R. Perng, 2007 .

Leukotriene modifier vs inhaled corticosteroid in mild-to-moderate asthma: clinical and anti-inflammatory effects.

R. Perng, D. Perng, Yu-chin Lee, 2004, Chest.

Association between Tumor Epidermal Growth Factor Receptor Mutation and Pulmonary Tuberculosis in Patients with Adenocarcinoma of the Lungs

Yuh-Min Chen, R. Perng, Chun-Ming Tsai, 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Chemotherapy for non-small cell lung cancer in elderly patients.

J. Whang‐Peng, Yuh-Min Chen, R. Perng, 2005, Chest.

Third‐line or fourth‐line chemotherapy in non‐small‐cell lung cancer patients with relatively good performance status

J. Whang‐Peng, Yuh-Min Chen, R. Perng, 2011, Journal of the Chinese Medical Association : JCMA.

Phase II study of ifosfamide and etoposide chemotherapy for extensive-disease small-cell lung cancer.

J. Whang‐Peng, R. Perng, C. Tsai, 1997, Japanese journal of clinical oncology.

Superior vena cava syndrome revisited.

R. Perng, C. Tsai, Y. Chen, 1995, Japanese journal of clinical oncology.

The Association Between Tumor Epidermal Growth Factor Receptor (EGFR) Mutation and Multiple Primary Malignancies in Patients With Adenocarcinoma of the Lungs

J. Whang‐Peng, T. Chou, C. Chiu, 2015, American journal of clinical oncology.

A Phase II Randomized Trial of Gefitinib Alone or with Tegafur/Uracil Treatment in Patients with Pulmonary Adenocarcinoma Who had Failed Previous Chemotherapy

J. Whang‐Peng, T. Chou, Yuh-Min Chen, 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Neutrophil elastase stimulates human airway epithelial cells to produce PGE2 through activation of p44/42 MAPK and upregulation of cyclooxygenase-2.

R. Perng, Yu-Chung Wu, W. Hsu, 2003, American journal of physiology. Lung cellular and molecular physiology.

Risk Factor Analysis of Acute Respiratory Distress Syndrome Among Hospitalized Patients with Chlamydophila pneumoniae Pneumonia

R. Perng, Kuang-Yao Yang, Kuan-Ting Liu, 2007, Journal of the Chinese Medical Association : JCMA.

Clinical Features and Outcomes of Severe Acute Respiratory Syndrome and Predictive Factors for Acute Respiratory Distress Syndrome

R. Perng, Cheng-yi Liu, Chen-Hsen Lee, 2005, Journal of the Chinese Medical Association.

Phase II randomized study of daily gefitinib treatment alone or with vinorelbine every 2 weeks in patients with adenocarcinoma of the lung who failed at least 2 regimens of chemotherapy

J. Whang‐Peng, T. Chou, Yuh-Min Chen, 2007, Cancer.

A phase II trial of vinorelbine plus gemcitabine in previously untreated inoperable (stage IIIb/IV) non-small-cell lung cancer patients aged 80 or older.

J. Whang‐Peng, Yuh-Min Chen, R. Perng, 2003, Lung cancer.

Efficacy and safety of erlotinib in >1200 East/South-East (E/SE) Asian patients (pts) with advanced non-small-cell lung cancer (NSCLC)

T. Mok, R. Perng, Y. Wu, 2008 .

Sarcoidosis among Chinese in Taiwan.

R. Perng, T. Tsai, W. Hsieh, 1997, Journal of the Formosan Medical Association = Taiwan yi zhi.

Usage of Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor (EGFR-TKI) in Tumor EGFR Wild-Type or Unknown Non-Small Cell Lung Cancer

J. Whang‐Peng, Yuh-Min Chen, R. Perng, 2013 .

Foreign body aspiration into the lower airway in Chinese adults.

R. Perng, Chun-Liang Lai, C. Lai, 1996, Chest.

Phase II study with vinorelbine and cisplatin in advanced non-small cell lung cancer after failure of previous chemotherapy.

Yuh-Min Chen, R. Perng, Chia-San Lee, 2003, Journal of the Chinese Medical Association : JCMA.

A phase II randomized study of vinorelbine alone or with cisplatin against chemo-naïve inoperable non-small cell lung cancer in the elderly.

J. Whang‐Peng, Yuh-Min Chen, R. Perng, 2008, Lung cancer.

A phase II trial of gemcitabine plus UFUR combination chemotherapy in non-small-cell lung cancer patients failing previous chemotherapy.

J. Whang‐Peng, Yuh-Min Chen, R. Perng, 2006, Lung Cancer.

Pleural Effusion as the Initial Clinical Presentation in Pulmonary Cryptococcosis: A Report of a Case with Unusual Manifestation, and a Literature Review

R. Perng, C. Chiang, C. Hsieh, 2003 .

Enhancement of fluorinated pyrimidine‐induced cytotoxicity by leucovorin in human lung cancer cell lines

B. Kramer, A. Gazdar, R. Perng, 1990, International Journal of Cancer.

The role of fiberoptic bronchoscopy in evaluating the causes of pleural effusions.

R. Perng, Shi‐Chuan Chang, 1989, Archives of internal medicine.

Hepatocellular carcinoma with Pancoast's syndrome as an initial symptom: a case report.

R. Perng, W. Su, C. F. Chang, 2001, Japanese journal of clinical oncology.

P-544 Final results of a phase I study with navelbine (NVB) oral in combination with cisplatin (C), evaluating two different schedules in advanced non-small cell lung cancer (NSCLC) patients

Yuh-Min Chen, R. Perng, Pan‐Chyr Yang, 2003 .

Restoration of the Immunocompetence by IL‐2 Activation and TCR‐CD3 Engagement of the In Vivo Anergized Tumor‐Specific CTL from Lung Cancer Patients

J. Whang‐Peng, Yuh-Min Chen, R. Perng, 1997, Journal of immunotherapy.

Endobronchial Foreign Body Leading to Lung Torsion

R. Perng, M. Chern, Chung-Hua Chen, 1996 .

Keunchil Park, Yuh-Min Chen, R. Perng, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Treatment of non-small-cell lung cancer: the Chinese experience in a general teaching hospital.

R. Perng, S. Yen, C. Tsai, 2000, Zhonghua yi xue za zhi = Chinese medical journal; Free China ed.

Sialyl stage-specific embryonic antigen-1: a useful marker for differentiating the etiology of pleural effusion.

R. Perng, S. Lai, Y. Lee, 1998, Chest.

[Anaphylactic shock after readministration of rifampicin: a case report].

R. Perng, W. Su, S. Chiang, 1992, Zhonghua yi xue za zhi = Chinese medical journal; Free China ed.

Cisplatin-Based Three Drugs Combination (NIP) as Induction and Adjuvant Treatment in Locally Advanced Non-small Cell Lung Cancer: Final Results

R. Perng, R. Ramlau, M. Krzakowski, 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Clinical experience in using polymerase chain reaction for rapid diagnosis of pulmonary tuberculosis.

R. Perng, A. Tsou, W. Su, 2000, Zhonghua yi xue za zhi = Chinese medical journal; Free China ed.

Phase II randomized trial of tri-weekly versus days 1 and 8 weekly docetaxel as a second-line treatment of advanced non-small cell lung cancer.

C. Chiu, Yuh-Min Chen, R. Perng, 2005, Japanese journal of clinical oncology.

Phase II randomized trial of erlotinib versus vinorelbine in chemotherapy-naive patients with advanced non-small-cell lung cancer (NSCLC) aged ≥70 years in Taiwan.

J. Whang‐Peng, R. Perng, C. Tsai, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Symptomatic ocular metastases in lung cancer

Yuh-Min Chen, R. Perng, H. Su, 2008, Respirology.

Tracheal bronchus associated with lung cancer: a case report.

R. Perng, Y. Lee, R. Perng, 1999, Chest.

Elevated levels of carcinoembryonic antigen and cancer antigen 125 in a thymic cyst.

R. Perng, W. Su, C. Hua, 1993 .